H. Weiss

2.6k total citations
82 papers, 2.1k citations indexed

About

H. Weiss is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, H. Weiss has authored 82 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 10 papers in Oncology. Recurrent topics in H. Weiss's work include ATP Synthase and ATPases Research (12 papers), Mitochondrial Function and Pathology (12 papers) and Receptor Mechanisms and Signaling (9 papers). H. Weiss is often cited by papers focused on ATP Synthase and ATPases Research (12 papers), Mitochondrial Function and Pathology (12 papers) and Receptor Mechanisms and Signaling (9 papers). H. Weiss collaborates with scholars based in Switzerland, France and Germany. H. Weiss's co-authors include Reinhard Grisshammer, Claude de Montigny, M Dumont, Y. Lamarre, Gerhard Groß, Olivier Kretz, Kevin Leonard, Uwe Nehls, Dieter Seebàch and Alain Schweitzer and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

H. Weiss

81 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Weiss Switzerland 26 1.3k 385 222 211 182 82 2.1k
Hirotaka Yamamoto Japan 29 1.5k 1.2× 586 1.5× 245 1.1× 185 0.9× 89 0.5× 96 2.7k
Giovanna Di Trapani Italy 24 853 0.7× 172 0.4× 346 1.6× 181 0.9× 120 0.7× 89 2.3k
Davide Cervia Italy 35 1.3k 1.0× 314 0.8× 266 1.2× 155 0.7× 97 0.5× 88 2.7k
Jordan B. Fishman United States 20 816 0.7× 253 0.7× 294 1.3× 193 0.9× 72 0.4× 57 1.6k
Nobuo Katsube Japan 25 1.1k 0.8× 411 1.1× 341 1.5× 126 0.6× 181 1.0× 53 2.3k
Da Duan China 19 2.2k 1.7× 575 1.5× 183 0.8× 248 1.2× 376 2.1× 39 3.0k
Takeshi Tomita Japan 30 1.2k 1.0× 258 0.7× 375 1.7× 217 1.0× 327 1.8× 165 3.8k
Tarun B. Patel United States 36 2.2k 1.7× 439 1.1× 506 2.3× 401 1.9× 202 1.1× 97 3.3k
Xiaoguang Liu China 26 1.1k 0.9× 271 0.7× 235 1.1× 236 1.1× 74 0.4× 118 2.4k
Ming Fan China 29 1.1k 0.9× 212 0.6× 174 0.8× 287 1.4× 252 1.4× 95 2.2k

Countries citing papers authored by H. Weiss

Since Specialization
Citations

This map shows the geographic impact of H. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Weiss more than expected).

Fields of papers citing papers by H. Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Weiss. The network helps show where H. Weiss may publish in the future.

Co-authorship network of co-authors of H. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of H. Weiss. A scholar is included among the top collaborators of H. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Weiss. H. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frías, Juan P., Robert Schmouder, Eric Lawitz, et al.. (2025). Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction–Associated Steatohepatitis. Alimentary Pharmacology & Therapeutics. 63(5). 637–647. 1 indexed citations
2.
Loesche, Christian, D Picard, Gebhard Thoma, et al.. (2024). LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial. Clinical and Translational Science. 17(2). e13724–e13724. 2 indexed citations
3.
Brightling, Christopher E., Swarupa G. Kulkarni, Bart N. Lambrecht, et al.. (2021). The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant. Pulmonary Pharmacology & Therapeutics. 68. 102030–102030. 6 indexed citations
4.
Weiss, H., et al.. (2020). A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach. Drug Metabolism and Disposition. 48(10). 917–924. 4 indexed citations
5.
Poller, Birk, Ralph Woessner, Avantika Barve, et al.. (2019). Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes. Pulmonary Pharmacology & Therapeutics. 57. 101809–101809. 8 indexed citations
6.
Barch, Deanna M., Stephen R. Marder, Michael P. Harms, et al.. (2016). Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 71. 66–75. 9 indexed citations
7.
Khindri, Sanjeev, et al.. (2011). Efficient deposition and absorption of orally inhaled indacaterol in the lungs. European Respiratory Journal. 38(Suppl 55). p252–p252. 4 indexed citations
8.
Weiss, H., et al.. (2008). Biodistribution and Plasma Protein Binding of Zoledronic Acid. Drug Metabolism and Disposition. 36(10). 2043–2049. 132 indexed citations
9.
Kovarik, John M., Robert Schmouder, Stefan Hartmann, et al.. (2006). Fingolimod (FTY720) in Severe Hepatic Impairment: Pharmacokinetics and Relationship to Markers of Liver Function. The Journal of Clinical Pharmacology. 46(2). 149–156. 23 indexed citations
10.
Kretz, Olivier, H. Weiss, M. Schumacher, & Gerhard Groß. (2004). In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemia. British Journal of Clinical Pharmacology. 58(2). 212–216. 68 indexed citations
11.
Haase, Winfried, H. Weiss, & Helmut Reiländer. (1998). Localization of the myc-Tagged 5HT5A Receptor by Immunogold Staining of Ultrathin Sections. Methods in molecular biology. 103. 241–247. 1 indexed citations
12.
Buldakova, Svetlana, et al.. (1995). Temperature change-induced potentiation: A comparative study of facilitatory mechanisms in aged and young rat hippocampal slices. Neuroscience. 68(2). 395–397. 9 indexed citations
13.
Reignier, Jean, Michel Mazmanian, Hélène Détruit, et al.. (1994). Reduction of Ischemia-Reperfusion Injury by Pentoxifylline in the Isolated Rat Lung. Paris-Sud University Lung Transplantation Group. American Journal of Respiratory and Critical Care Medicine. 150(2). 342–347. 29 indexed citations
14.
15.
Nehls, Uwe, et al.. (1991). cDNA and genomic DNA sequence of the 21.3 kDa subunit of NADH: ubiquinone reductase (complex I) from Neurospora crassa. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1088(2). 325–326. 14 indexed citations
16.
Weidner, Uwe, et al.. (1991). Primary structure of the nuclear-encoded 29.9 kDa subunit of NADH: Ubiquinone reductase from Neurospora crassa mitochondria. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1089(3). 389–390. 23 indexed citations
17.
18.
Brunori, Maurizio, Maria Chiara Silvestrini, M.T. Wilson, & H. Weiss. (1983). Transient kinetic studies of Neurospora crassa cytochrome c oxidase. Biochemical Journal. 215(2). 425–427. 3 indexed citations
19.
Bücher, Theodor, et al.. (1980). Biological chemistry of organelle formation : 31. Colloquium der Gesellschaft für Biologische Chemie, 14.-19. April 1980 in Mosbach/Baden. Springer eBooks. 1 indexed citations
20.
Weiss, H.. (1978). [Influence of the olivo-cerebello-bulbar system on the motor neurons of the lumbar spinal cord in the cat after administration of harmaline].. PubMed. 116(1). 1–15. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotaka Yamamoto Breakdown of academic impact, for papers by Giovanna Di Trapani Breakdown of academic impact, for papers by Davide Cervia Breakdown of academic impact, for papers by Jordan B. Fishman Breakdown of academic impact, for papers by Nobuo Katsube Breakdown of academic impact, for papers by Da Duan Breakdown of academic impact, for papers by Takeshi Tomita Breakdown of academic impact, for papers by Tarun B. Patel Breakdown of academic impact, for papers by Xiaoguang Liu Breakdown of academic impact, for papers by Ming Fan
Rankless by CCL
2026